This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Leibniz-Institut Fuer Plasmaforschun Und Technologie E.v. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Olaf Lademann
Introduction
Olaf Lademann is a notable inventor based in Rostock, Germany. He has made significant contributions to the field of plasma technology, particularly in the treatment of living cells. His innovative approach combines advanced plasma generation with the delivery of active substances, showcasing his expertise in the intersection of technology and biology.
Latest Patents
Lademann holds a patent for an "Atmospheric pressure plasma jet for delivering active substances encapsulated in nanoparticles or microparticles to tissue." This device is designed for treating living cells through a process known as plasmaporation. It includes mechanisms for generating plasma and creating a field, as well as systems for mixing and transporting active substances, primarily in the form of nano and microparticles. This invention aims to influence the metabolism of cells, highlighting Lademann's commitment to advancing medical technology.
Career Highlights
Throughout his career, Olaf Lademann has worked with esteemed institutions such as the Leibniz Institute for Plasma Research and Technology. His work at these organizations has allowed him to develop and refine his innovative ideas, contributing to the broader field of plasma technology and its applications in medicine.
Collaborations
Lademann has collaborated with notable colleagues, including Klaus-Dieter Weltmann and Thomas Von Woedtke. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their shared field of research.
Conclusion
Olaf Lademann's contributions to plasma technology and his innovative patent demonstrate his significant impact on the field. His work continues to inspire advancements in medical treatments and technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile